Figure 3 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy

Q: What type of study is this?

This is a Quantitative Study study.

Howard L. Li; Soren Charmsaz; Mari Nakazawa; Stephanie Alden; Madelena Brancati; James M. Leatherman; Ervin Griffin; Hua‐Ling Tsai; Nicole Groß; Christopher J. Thoburn; Alexei Hernandez; Erin M. Coyne; Sarah M. Shin; Royce P. Lee; Evan J. Lipson; Burles A. Johnson; Aliyah Pabani; Yasser Ged; Marina Baretti; Julie R. Brahmer; Jean Hoffman‐Censits; Tanguy Y. Seiwert; Daniel J. Zabransky; Jennifer N. Durham; Elizabeth M. Jaffee; G. Scott Chandler; Brittany L. Adler; Won Jin Ho; Chester Kao; Mark Yarchoan

doi:10.1158/2767-9764.30256047

Key Points

Patients with ICI-related fatigue experienced different clinical outcomes compared to those without fatigue.
Visualization indicates a clear distinction in the best response to ICI therapy for fatigued versus non-fatigued patients.
Using a stacked bar plot, the study presents a comparative analysis of responses to treatment.
These findings highlight the importance of recognizing fatigue in treatment strategies for cancer patients.

Implication

Analysis shows associations between clinical outcomes and ICI-related fatigue in patients, highlighting potential therapeutic insights.

Abstract

Associations between clinical outcomes and ICI-related fatigue. Stacked bar plot visualizing the best response to ICIs in patients with ICI-related fatigue vs. patients without ICI-related fatigue.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a217c8 https://doi.org/10.1158/2767-9764.30256047

View Full Paper

Ask AI

Bookmark

Share

Figure 3 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Figure 3 from Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading